Literature DB >> 21478828

Genzyme-Sanofi buy out is second largest biotech deal ever.

Mark Ratner.   

Abstract

Mesh:

Year:  2011        PMID: 21478828     DOI: 10.1038/nbt0411-293

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Novartis eyes oral MS drug as potential blockbuster.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2010-11       Impact factor: 54.908

2.  Sanofi Aventis grooms its ranks for biotech partnering.

Authors:  Nuala Moran
Journal:  Nat Biotechnol       Date:  2009-07       Impact factor: 54.908

  2 in total
  1 in total

1.  Big pharma upheavals cast shadow across biotech sector.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2012-02-08       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.